The Value of Chemical Fat-saturation Pulse Added to T1-weighted Spin-echo Sequence in Evaluating Gadolinium-enhancing Brain Lesions in Multiple Sclerosis

Overview

Journal Radiol Med

Specialty Radiology

Date 2007 Dec 15

PMID 18080095

Citations 2

Authors

F Sardanelli

S Schiavoni

A Iozzelli

A Fausto

A Aliprandi

G L Mancardi

M Filippi

Affiliations

Soon will be listed here.

Abstract

Purpose: This study was undertaken to assess the value of a chemical (spectral) fat-saturation (fat-sat) pulse added to a T1-weighted spin-echo sequence after intravenous administration of paramagnetic contrast agent in detecting enhancing lesions in multiple sclerosis.

Materials And Methods: Twenty patients with relapsing-remitting multiple sclerosis underwent a brain 1.0-Tesla magnetic resonance (MR) scan with T1-weighted spin-echo sequences (24 contiguous para-axial slices with a thickness of 5 mm, pixel size 0.96 mm(2), number of excitations 2, flip angle 90 degrees ) 5 min after intravenous injection of 0.1 mmol/kg of gadodiamide with and without fat-sat, acquired with randomised order of priority. Two readers counted by consensus the number of enhancing lesions and assigned a conspicuity score (low conspicuity=1; high conspicuity=2) to each enhancing lesion during a randomised reading without any visual comparison between the two corresponding images (with and without fat-sat) of the same patient. McNemar and Wilcoxon matched-pair signed-rank tests were used.

Results: Seventy-two enhancing lesions without fat-sat and 94 with fat-sat were detected; 22 lesions were visible only with fat-sat, whereas no lesion was detected only without fat-sat (p<0.0001). The conspicuity score was 1.17+/-0.38 (mean+/-standard deviation) and 1.57+/-0.44, respectively (p<0.0001).

Conclusions: A fat-sat pulse added to a T1-weighted spin-echo sequence increases significantly the number and conspicuity of contrast-enhancing lesions in patients with relapsing-remitting multiple sclerosis.

Citing Articles

Diagnostic image quality of gadolinium-enhanced T1-weighted MRI with and without fat saturation in children with retinoblastoma.

Sirin S, Schlamann M, Metz K, Bornfeld N, Schweiger B, Holdt M Pediatr Radiol. 2013; 43(6):716-24.

PMID: 23314985 DOI: 10.1007/s00247-012-2576-y.

Pyrolytic graphite foam: a passive magnetic susceptibility matching material.

Lee G, Goodwill P, Phuong K, Inglis B, Scott G, Hargreaves B J Magn Reson Imaging. 2010; 32(3):684-91.

PMID: 20815067 PMC: 3525090. DOI: 10.1002/jmri.22270.

References

Rovaris M, Codella M, Moiola L, Ghezzi A, Zaffaroni M, Mancardi G . Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses. Neurology. 2002; 59(9):1429-32. DOI: 10.1212/01.wnl.0000033800.93899.e1. View

Fazekas F, Barkhof F, Filippi M, Grossman R, Li D, McDonald W . The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology. 1999; 53(3):448-56. DOI: 10.1212/wnl.53.3.448. View

Jackson E, Ginsberg L, Schomer D, Leeds N . A review of MRI pulse sequences and techniques in neuroimaging. Surg Neurol. 1997; 47(2):185-99. DOI: 10.1016/s0090-3019(96)00375-8. View

Renzetti P, Parodi R, Losacco C, Rosso E, Arcuri T, Sardanelli F . [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration]. Radiol Med. 1999; 98(3):138-43. View

McDonald W, Compston A, Edan G, Goodkin D, Hartung H, Lublin F . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50(1):121-7. DOI: 10.1002/ana.1032. View

Bastianello S, Gasperini C, Paolillo A, Giugni E, Ciccarelli O, Sormani M . Sensitivity of enhanced MR in multiple sclerosis: effects of contrast dose and magnetization transfer contrast. AJNR Am J Neuroradiol. 1999; 19(10):1863-7. PMC: 8337734. View

Filippi M . Enhanced magnetic resonance imaging in multiple sclerosis. Mult Scler. 2000; 6(5):320-6. DOI: 10.1177/135245850000600505. View

Fujii Y, Konishi Y, Kuriyama M, Hori C, Sudo M . Lipoma on surface of centroparietal lobes. Pediatr Neurol. 1993; 9(2):144-6. DOI: 10.1016/0887-8994(93)90052-e. View

Filippi M, Rovaris M, Capra R, Gasperini C, Yousry T, Sormani M . A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain. 1998; 121 ( Pt 10):2011-20. DOI: 10.1093/brain/121.10.2011. View

10.

Losseff N, KINGSLEY D, McDonald W, Miller D, Thompson A . Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis. Mult Scler. 1996; 1(4):218-22. View

11.

Koudriavtseva T, Thompson A, Fiorelli M, Gasperini C, Bastianello S, Bozzao A . Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 1997; 62(3):285-7. PMC: 1064162. DOI: 10.1136/jnnp.62.3.285. View

12.

Jackson A, Sheppard S, Laitt R, Kassner A, Moriarty D . Optic neuritis: MR imaging with combined fat- and water-suppression techniques. Radiology. 1998; 206(1):57-63. DOI: 10.1148/radiology.206.1.9423652. View

13.

Truyen L, van Waesberghe J, van Walderveen M, van Oosten B, Polman C, Hommes O . Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 1996; 47(6):1469-76. DOI: 10.1212/wnl.47.6.1469. View

14.

Sardanelli F, Losacco C, Iozzelli A, Renzetti P, Rosso E, Parodi R . Evaluation of Gd-enhancement in brain MR of multiple sclerosis: image subtraction with and without magnetization transfer. Eur Radiol. 2002; 12(8):2077-82. DOI: 10.1007/s00330-001-1228-7. View

15.

van Waesberghe J, Kamphorst W, de Groot C, van Walderveen M, Castelijns J, Ravid R . Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 1999; 46(5):747-54. DOI: 10.1002/1531-8249(199911)46:5<747::aid-ana10>3.3.co;2-w. View

16.

Guy J, Mao J, Bidgood Jr W, Mancuso A, Quisling R . Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging. Ophthalmology. 1992; 99(5):713-9. DOI: 10.1016/s0161-6420(92)31892-5. View

17.

Mao J, Yan H, Brey W, Bidgood Jr W, Steinbach J, Mancuso A . Fat tissue and fat suppression. Magn Reson Imaging. 1993; 11(3):385-93. DOI: 10.1016/0730-725x(93)90071-k. View

18.

Filippi M, Yousry T, Baratti C, Horsfield M, Mammi S, Becker C . Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain. 1996; 119 ( Pt 4):1349-55. DOI: 10.1093/brain/119.4.1349. View

19.

Seitz J, Held P, Strotzer M, Volk M, Nitz W, Dorenbeck U . MR imaging of cranial nerve lesions using six different high-resolution T1- and T2(*)-weighted 3D and 2D sequences. Acta Radiol. 2002; 43(4):349-53. DOI: 10.1080/j.1600-0455.2002.430401.x. View

20.

Delfaut E, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A . Fat suppression in MR imaging: techniques and pitfalls. Radiographics. 1999; 19(2):373-82. DOI: 10.1148/radiographics.19.2.g99mr03373. View